Bilaketaren emaitzak - Anthony Ivetac
- Erakusten 1 - 11 emaitzak -- 11
-
1
-
2
-
3
Molecular Recognition in the Case of Flexible Targets nork Anthony Ivetac, J. Andrew McCammon
Argitaratua 2011Artigo -
4
-
5
-
6
Coarse-Grained MD Simulations of Membrane Protein-Bilayer Self-Assembly nork Kathryn A. Scott, Peter J. Bond, Anthony Ivetac, Alan Chetwynd, Syma Khalid, Mark S.P. Sansom
Argitaratua 2008Artigo -
7
Cystic Fibrosis Transmembrane Conductance Regulator: A Molecular Model Defines the Architecture of the Anion Conduction Path and Locates a “Bottleneck” in the Pore nork Yohei Norimatsu, Anthony Ivetac, Christopher W. Alexander, John Kirkham, Nicolette O’Donnell, David C. Dawson, Mark S.P. Sansom
Argitaratua 2012Artigo -
8
Cystic Fibrosis Transmembrane Conductance Regulator: Using Differential Reactivity toward Channel-Permeant and Channel-Impermeant Thiol-Reactive Probes To Test a Molecular Model fo... nork Christopher W. Alexander, Anthony Ivetac, Xuehong Liu, Yohei Norimatsu, José Ramón Serrano, Allison Landstrom, Mark S.P. Sansom, David C. Dawson
Argitaratua 2009Artigo -
9
Fragment-Based Discovery of MRTX1719, a Synthetic Lethal Inhibitor of the PRMT5•MTA Complex for the Treatment of <i>MTAP</i>-Deleted Cancers nork Christopher R. Smith, Ruth Aranda, Thomas P. Bobinski, David M. Briere, Aaron C. Burns, James G. Christensen, Jeffery Clarine, Lars D. Engstrom, Robin J. Gunn, Anthony Ivetac, Ronald Jean-Baptiste, John M. Ketcham, Masakazu Kobayashi, Jon Kuehler, Svitlana Kulyk, J. David Lawson, Krystal Moya, Peter Olson, Lisa Rahbæk, Nicole C. Thomas, Xiaolun Wang, Laura Waters, Matthew A. Marx
Argitaratua 2022Artigo -
10
Design and Discovery of MRTX0902, a Potent, Selective, Brain-Penetrant, and Orally Bioavailable Inhibitor of the SOS1:KRAS Protein–Protein Interaction nork John M. Ketcham, Jacob R. Haling, Shilpi Khare, Vickie Bowcut, David M. Briere, Aaron C. Burns, Robin J. Gunn, Anthony Ivetac, Jon Kuehler, Svitlana Kulyk, Jade Laguer, J. David Lawson, Krystal Moya, Natalie Nguyen, Lisa Rahbæk, Barbara Saechao, Christopher R. Smith, Niranjan Sudhakar, Nicole C. Thomas, Laura Vegar, Darin Vanderpool, Xiaolun Wang, Larry Yan, Peter Olson, James G. Christensen, Matthew A. Marx
Argitaratua 2022Artigo -
11
The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading nork Niranjan Sudhakar, Larry Yan, Fadia Qiryaqos, Lars D. Engstrom, Jade Laguer, Andrew Calinisan, Allan Hebbert, Laura Waters, Krystal Moya, Vickie Bowcut, Laura Vegar, John M. Ketcham, Anthony Ivetac, Christopher R. Smith, J. David Lawson, Lisa Rahbæk, Jeffrey Clarine, Natalie Nguyen, Barbara Saechao, Cody Parker, A. J. ELLIOTT, Darin Vanderpool, Leo He, Laura D. Hover, Julio Fernandez-Banet, Sílvia Coma, Jonathan A. Pachter, Jill Hallin, Matthew A. Marx, David M. Briere, James G. Christensen, Peter Olson, Jacob R. Haling, Shilpi Khare
Argitaratua 2024Artigo
Bilaketa egiteko lanabesak:
Antzeko gaiak
Biology
Chemistry
Biochemistry
Computational chemistry
Molecular dynamics
Gene
Biophysics
Computational biology
Mathematics
Medicine
Receptor
Computer science
Drug discovery
Materials science
Virtual screening
Allosteric regulation
Cancer research
Chemical physics
Combinatorics
Conductance
Crystallography
Cystic fibrosis transmembrane conductance regulator
Docking (animal)
Druggability
Enzyme
Flexibility (engineering)
G protein-coupled receptor
Membrane
Nanotechnology
Nursing